CME Group (CME) Stock Forecast & Price Target
CME Analyst Ratings
Moderate Buy
6Buy4Hold2Sell
Based on 12 analysts giving stock ratings to CME Group in the past 3 months
CME Stock 12 Month Forecast
Average Price Target
MXN 5,791.90â–²(0.61% Upside)Based on 12 Wall Street analysts offering 12 month price targets for CME Group in the last 3 months. The average price target is MXN 5,791.90 with a high forecast of MXN 6,856.87 and a low forecast of MXN 4,241.17. The average price target represents a 0.61% change from the last price of MXN 5,757.00.
Past 12 Months12 Month ForecastDec2025Sep2026
HighMXN 6.86K
AverageMXN 5.79K
LowMXN 4.24K
Highest Price TargetHighestMXN 6,856.87Average Price TargetMXN 5,791.90Lowest Price TargetLowestMXN 4,241.17
Detailed List of Analyst Forecasts​
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Alexander Blostein | Goldman Sachs | MXN 4,745.62→MXN 5,063.24 | sell | -12.05%Downside | Reiterated | 10/23/26 | ||
| Benjamin Budish | Barclays | MXN 5,044.56→MXN 5,997.42 | hold | 4.18%Upside | Reiterated | 10/22/26 | ||
| Daniel Welden | Wells Fargo | MXN 5,885.32→MXN 6,221.62 | buy | 8.07%Upside | Assigned | 10/22/26 | ||
| Christopher Allen | KBW | MXN 6,072.16→MXN 6,165.57 | buy | 7.10%Upside | Reiterated | 10/22/26 | ||
| Michael Cyprys | Morgan Stanley | MXN 6,296.36→MXN 6,707.40 | buy | 16.51%Upside | Reiterated | 10/22/26 | ||
| Ken Worthington | J.P. Morgan | MXN 4,670.89→MXN 6,856.87 | buy | 19.10%Upside | Upgraded | 10/22/26 | ||
| Alex Kramm | UBS | MXN 5,044.56→MXN 5,791.90 | hold | 0.61%Upside | Reiterated | 10/22/26 | ||
| Patrick Moley | Piper Sandler | MXN 5,511.65→MXN 6,165.57 | buy | 7.10%Upside | Reiterated | 10/22/26 | ||
| Craig Siegenthaler | Bank of America Securities | MXN 4,073.02→MXN 4,241.17 | sell | -26.33%Downside | Reiterated | 10/21/26 | ||
| Ashish Sabadra | RBC Capital | MXN 5,642.43 | hold | -1.99%Downside | Reiterated | 10/20/26 | ||
| William Katz | TD Cowen | MXN 5,455.60→MXN 5,605.07 | buy | -2.64%Downside | Reiterated | 10/05/26 | ||
| Brian Bedell | Deutsche Bank | MXN 5,044.56 | hold | -12.38%Downside | Downgraded | 08/19/26 | ||
| Hans Engel | Erste Group | ― | hold | ― | Reiterated | 06/24/26 | ||
| Simon Clinch | Rothschild & Co Redburn | MXN 6,034.79 | buy | 4.83%Upside | Upgraded | 06/11/26 | ||
| Kevin Heal | Argus Research | ― | hold | ― | Downgraded | 03/03/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Alexander Blostein | 10/23/26 | MXN 4,745.62→MXN 5,063.24 | sell | -12.05%Downside | Reiterated | Goldman Sachs | ||
| Benjamin Budish | 10/22/26 | MXN 5,044.56→MXN 5,997.42 | hold | 4.18%Upside | Reiterated | Barclays | ||
| Daniel Welden | 10/22/26 | MXN 5,885.32→MXN 6,221.62 | buy | 8.07%Upside | Assigned | Wells Fargo | ||
| Christopher Allen | 10/22/26 | MXN 6,072.16→MXN 6,165.57 | buy | 7.10%Upside | Reiterated | KBW | ||
| Michael Cyprys | 10/22/26 | MXN 6,296.36→MXN 6,707.40 | buy | 16.51%Upside | Reiterated | Morgan Stanley | ||
| Ken Worthington | 10/22/26 | MXN 4,670.89→MXN 6,856.87 | buy | 19.10%Upside | Upgraded | J.P. Morgan | ||
| Alex Kramm | 10/22/26 | MXN 5,044.56→MXN 5,791.90 | hold | 0.61%Upside | Reiterated | UBS | ||
| Patrick Moley | 10/22/26 | MXN 5,511.65→MXN 6,165.57 | buy | 7.10%Upside | Reiterated | Piper Sandler | ||
| Craig Siegenthaler | 10/21/26 | MXN 4,073.02→MXN 4,241.17 | sell | -26.33%Downside | Reiterated | Bank of America Securities | ||
| Ashish Sabadra | 10/20/26 | MXN 5,642.43 | hold | -1.99%Downside | Reiterated | RBC Capital | ||
| William Katz | 10/05/26 | MXN 5,455.60→MXN 5,605.07 | buy | -2.64%Downside | Reiterated | TD Cowen | ||
| Brian Bedell | 08/19/26 | MXN 5,044.56 | hold | -12.38%Downside | Downgraded | Deutsche Bank | ||
| Hans Engel | 06/24/26 | ― | hold | ― | Reiterated | Erste Group | ||
| Simon Clinch | 06/11/26 | MXN 6,034.79 | buy | 4.83%Upside | Upgraded | Rothschild & Co Redburn | ||
| Kevin Heal | 03/03/26 | ― | hold | ― | Downgraded | Argus Research |
Stocks with the Highest Top Analyst Consensus in the Financial Sector
Best Analysts Covering CME Group
3 Months
Success Rate12/15 ratings generated profit
80%
Average Return
+7.75%
Copying Christopher Allen's trades and holding each position for 3 Months would result in 80.00% of your transactions generating a profit, with an average return of +7.75% per trade.
1 Year
Success Rate14/15 ratings generated profit
93%
Average Return
+14.16%
Copying Christopher Allen's trades and holding each position for 1 Year would result in 93.33% of your transactions generating a profit, with an average return of +14.16% per trade.
2 Years
Success Rate19/19 ratings generated profit
100%
Average Return
+27.96%
Copying Patrick Moley's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +27.96% per trade.
CME Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 8 | 10 | 10 | 9 | 13 |
| Hold | 16 | 14 | 15 | 10 | 8 |
| Sell | 6 | 6 | 6 | 4 | 4 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 30 | 30 | 31 | 23 | 25 |
In the current month, CME has received 13 Buy Ratings, 8 Hold Ratings, and 4 Sell Ratings. CME average Analyst price target in the past 3 months is 5,791.90.
CME Financial Forecast
HighMXN 61.64
ConsensusMXN 56.86
LowMXN 54.87
CME Earnings Forecast
Next quarter’s earnings estimate for CME is MXN 56.86 with a range of MXN 54.87 to MXN 61.64. The previous quarter’s EPS was MXN 56.75. Its overall industry beat the EPS estimate 81.82% of the time in the past 12 months.
HighMXN 33.8B
ConsensusMXN 33.1B
LowMXN 32.4B
CME Sales Forecast
Next quarter’s sales forecast for CME is MXN 33.12B with a range of MXN 32.36B to MXN 33.79B. The previous quarter’s sales results were MXN 32.65B. Its overall industry beat sales estimates 93.33% of the time in the past 12 months.
CME Stock Forecast FAQ
What is MX:CME’s average 12-month price target, according to analysts?
Based on analyst ratings, CME Group’s 12-month average price target is Mex$5,791.90.
What is MX:CME’s upside potential, based on the analysts’ average price target?
CME Group has 0.61% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CME Group a Buy, Sell or Hold?
CME Group has a consensus rating of Moderate Buy, which is based on 6 buy ratings, 4 hold ratings and 2 sell ratings.
What is CME Group’s share price target?
The average share price target for CME Group is Mex$5,791.90. This is based on 12 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is Mex$6,856.87, and the lowest forecast is Mex$4,241.17. The average share price target represents a 0.61% increase from the current price of Mex$5,757.
What do analysts say about CME Group?
CME Group’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 12 Wall Street analysts.
How can I buy shares of CME Group?
To buy shares of MX:CME, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
